MSI Financial Services’s Ionis Pharmaceuticals IONS Stock Holding History

MSI Financial Services’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$41K	Sell	857 -1,000	-54%	-$39.6K	﹤0.01%	1996
2016 Q3	$68K	Buy	1,857 +736	+66%	+$23K	﹤0.01%	1640
2016 Q2	$26K	Sell	1,121 -490	-30%	-$15.8K	﹤0.01%	2187
2016 Q1	$65K	Buy	1,611 +771	+92%	+$31.3K	﹤0.01%	1583
2015 Q4	$52K	Buy	840 +413	+97%	+$22.3K	﹤0.01%	1697
2015 Q3	$17K	Sell	427 -65	-13%	-$3.36K	﹤0.01%	1803
2015 Q2	$28K	Buy	492 +220	+81%	+$14K	﹤0.01%	1625
2015 Q1	$17K	Buy	272 +157	+137%	+$10.7K	﹤0.01%	1883
2014 Q4	$7K	Buy	115 +50	+77%	+$2.47K	﹤0.01%	2001
2014 Q3	$3K	Hold	65	–	–	﹤0.01%	2280
2014 Q2	$2K	Hold	65	–	–	﹤0.01%	2349
2014 Q1	$3K	Hold	65	–	–	﹤0.01%	2180
2013 Q4	$3K	Hold	65	–	–	﹤0.01%	2149
2013 Q3	$2K	Hold	65	–	–	﹤0.01%	1951
2013 Q2	$2K	Buy	+65	New	+$1.38K	﹤0.01%	2110

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MSI Financial Services's IONS Position: Q4 2016 in Review

MSI Financial Services reduced its Ionis Pharmaceuticals (IONS) stake by 54% in Q4 2016, selling an estimated $39.6K and leaving 857 shares worth $41K. The position accounts for ﹤0.01% of the portfolio, ranked #1996.

MSI Financial Services first reported a position in IONS in Q2 2013 and has held it in 15 quarters since. The position peaked at $68K in Q3 2016. 309 funds tracked by Wall St. Rank hold IONS as of Q4 2016.

MSI Financial Services held 857 shares of Ionis Pharmaceuticals worth $41K as of Q4 2016.
MSI Financial Services sold 1,000 Ionis Pharmaceuticals shares in Q4 2016, an estimated $39.6K.
Ionis Pharmaceuticals made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #1996 holding.
MSI Financial Services first reported a position in Ionis Pharmaceuticals in Q2 2013 and has held it in 15 quarters since.
MSI Financial Services's Ionis Pharmaceuticals position peaked at $68K in Q3 2016.
309 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.